Literature DB >> 25065958

Pragmatic design in randomized controlled trials.

M Purgato1, C Barbui1, S Stroup2, C Adams3.   

Abstract

At more than 10 years after the paper by Hotopf and colleagues regarding pragmatic trials in psychiatry, the field has evolved and is evolving further. There have been many developments in our understanding of what pragmatism really means, and excellent examples of truly pragmatic trials in psychiatry are currently available. Funders have helped encourage more emphasis on the need for such studies, but 'local' and trans-national regulations could help more. Consumers of the evidence should have a greater voice in generating the research agenda and, as this happens, the questions generated are more likely to be answered by a pragmatic approach to trials.

Keywords:  Pragmatic design; psychiatry; randomized controlled trials

Mesh:

Year:  2014        PMID: 25065958     DOI: 10.1017/S0033291714001275

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

1.  Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study.

Authors:  G Ostuzzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-30       Impact factor: 6.892

Review 2.  Practical clinical trials in psychopharmacology: a systematic review.

Authors:  Benedetto Vitiello
Journal:  J Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.153

3.  Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.

Authors:  Chiara Gastaldon; Franziska Mosler; Sarah Toner; Federico Tedeschi; Victoria Jane Bird; Corrado Barbui; Stefan Priebe
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

4.  Expectancy in placebo-controlled trials of psychedelics: if so, so what?

Authors:  Matt Butler; Luke Jelen; James Rucker
Journal:  Psychopharmacology (Berl)       Date:  2022-09-05       Impact factor: 4.415

5.  Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?

Authors:  Robin L Carhart-Harris; Anne C Wagner; Manish Agrawal; Hannes Kettner; Jerold F Rosenbaum; Adam Gazzaley; David J Nutt; David Erritzoe
Journal:  J Psychopharmacol       Date:  2021-04-22       Impact factor: 4.153

6.  Cohort Multiple Randomised Controlled Trials (cmRCT) design: efficient but biased? A simulation study to evaluate the feasibility of the Cluster cmRCT design.

Authors:  Alexander Pate; Jane Candlish; Matthew Sperrin; Tjeerd Pieter Van Staa
Journal:  BMC Med Res Methodol       Date:  2016-08-26       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.